microRNAs and Fragile X Syndrome
- PMID: 26663181
- DOI: 10.1007/978-3-319-22671-2_7
microRNAs and Fragile X Syndrome
Abstract
Fragile X syndrome (FXS) is one of the major causes for autism and mental retardation in humans. The etiology of FXS is linked to the expansion of the CGG trinucleotide repeats, r(CGG), suppressing the fragile X mental retardation 1 (FMR1) gene on the X chromosome, resulting in a loss of fragile X mental retardation protein (FMRP) expression, which is required for regulating normal neuronal connectivity and plasticity. Recent studies have further identified that microRNAs are involved in the mechanisms underlying FXS pathogenesis at three different developmental stages. During early embryogenesis before the blastocyst stage, an embryonic stem cell (ESC)-specific microRNA, miR-302, interferes with FMR1 mRNA translation to maintain the stem cell status and inhibit neural development. After blastocyst, the downregulation of miR-302 releases FMRP synthesis and subsequently leads to neuronal development; yet, in FXS, certain r(CGG)-derived microRNAs, such as miR-fmr1s, are expressed and accumulated and then induce DNA hypermethylation on the FMR1 gene promoter regions, resulting in transcriptional inactivation of the FMR1 gene and the loss of FMRP. In normal neuronal development, FMRP is an RNA-binding protein responsible for interacting with miR-125 and miR-132 to regulate the signaling of Group 1 metabotropic glutamate receptor (mGluR1) and N-methyl-D-aspartate receptor (NMDAR), respectively, and consequently affecting synaptic plasticity. As a result, the loss of FMRP impairs these signaling controls and eventually causes FXS-associated disorders, such as autism and mental retardation. Based on these current findings, this chapter will summarize the etiological causes of FXS and further provides significant insights into the molecular mechanisms underlying microRNA-mediated FXS pathogenesis and the related therapy development.
Keywords: FMR1; FMRP; Fragile X syndrome; RITS; RNAi; microRNA.
Similar articles
-
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.PLoS One. 2011;6(10):e26203. doi: 10.1371/journal.pone.0026203. Epub 2011 Oct 12. PLoS One. 2011. PMID: 22022567 Free PMC article.
-
Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.Sci Signal. 2008 Feb 5;1(5):pe6. doi: 10.1126/stke.15pe6. Sci Signal. 2008. PMID: 18272470 Review.
-
BDNF in fragile X syndrome.Neuropharmacology. 2014 Jan;76 Pt C:729-36. doi: 10.1016/j.neuropharm.2013.05.018. Epub 2013 May 29. Neuropharmacology. 2014. PMID: 23727436 Review.
-
CGG-repeat dynamics and FMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons.Mol Autism. 2016 Oct 6;7:42. doi: 10.1186/s13229-016-0105-9. eCollection 2016. Mol Autism. 2016. PMID: 27713816 Free PMC article.
-
Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.Hum Mol Genet. 2013 Mar 15;22(6):1180-92. doi: 10.1093/hmg/dds525. Epub 2012 Dec 18. Hum Mol Genet. 2013. PMID: 23250915 Free PMC article.
Cited by
-
Increased Serum Levels of miR-125b and miR-132 in Fragile X Syndrome: A Preliminary Study.Neurol Genet. 2022 Oct 26;8(6):e200024. doi: 10.1212/NXG.0000000000200024. eCollection 2022 Dec. Neurol Genet. 2022. PMID: 36313066 Free PMC article.
-
Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.Front Mol Neurosci. 2022 Jan 7;14:797253. doi: 10.3389/fnmol.2021.797253. eCollection 2021. Front Mol Neurosci. 2022. PMID: 35069111 Free PMC article. Review.
-
Urine microRNA Profiling Displays miR-125a Dysregulation in Children with Fragile X Syndrome.Cells. 2020 Jan 24;9(2):289. doi: 10.3390/cells9020289. Cells. 2020. PMID: 31991700 Free PMC article.
-
The Role of Non-Coding RNAs in Neurodevelopmental Disorders.Front Genet. 2019 Nov 20;10:1033. doi: 10.3389/fgene.2019.01033. eCollection 2019. Front Genet. 2019. PMID: 31824553 Free PMC article. Review.
-
Molecular Biomarkers in Fragile X Syndrome.Brain Sci. 2019 Apr 27;9(5):96. doi: 10.3390/brainsci9050096. Brain Sci. 2019. PMID: 31035599 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials